Home
Chemicals

Sector: Chemicals

Qualcomm leads Brazilian patent filings this year

Clarivate data covering 2018 to 2023 reveals a dynamic landscape, including booming industries and Lenovo’s entry into the top 100

Fujifilm uses UPC to sue old adversary Kodak

The Japanese photography giant’s actions stir old conflicts and boost the small number of East Asian companies using the new court

Does the impact of Markman orders vary by technology complexity?

Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?

Latest content

Covid-19 patent landscape confusion is a big concern for life sciences organisations

Providing new insights into recent filings, but patent landscape uncertainties may pose dangers in the wake of the pandemic

09 March 2021

Samsung, LG and South Korea’s trade secrets dilemma

The long read: Few countries are more focused on the threat of IP leaks to China than South Korea. But when it comes to shoring up legal protections for trade secrets, senior leaders have put on the brakes, anticipating threats to key industry players and national technology goals

03 March 2021

Dialog’s patents will boost Renesas’ fast growing licensing business

The purchase of the UK chipmaker will contribute to the monetisation programme’s potential, particularly within circuit technologies

19 February 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions

18 February 2021

Uptrend in oppositions could spell costly delays for Indian patent applicants

Practitioners say greater attention to detail during the prosecution process can head off frivolous challenges

15 February 2021

Ford CEO weighs in on “really embarrassing” South Korean battery trade secrets fight

With the auto giant set for a high-profile roll out of several new electric vehicles, the dispute between LG Chem and SK Innovation is once again in the spotlight

12 February 2021

How the rise of PTAB discretionary denials impacts Hatch-Waxman strategies

The recent rejection of a Mylan IPR petition – currently being challenged at the Federal Circuit – is good news for pharma patentees and bad news for generics

11 February 2021